title: Steady-state pattern electroretinogram following long term unilateral administration of timolol to ocular hypertensive subjects.
abstract: To determine whether long-term reduction of intraocular pressure leads to a corresponding preservation of the pattern electroretinogram (PERG), PERGs were studied in 21 patients with ocular hypertension who had received unilateral timolol therapy for a minimum of 6 years. The mean difference in intraocular pressure (IOP) between the placebo-treated and the timolol-treated eyes (over 6 years) was 2.4 mm Hg. Steady-state PERGs (16.0 rps) were obtained simultaneously in both eyes of each patient, with four check sizes (0.25, 0.5, 1.0 and 2.0 degrees). Significant (p less than 0.05) steady-state PERG deficits (i.e., amplitude more than two standard deviations below the mean value of age-matched controls) were observed in 16 eyes of 12 patients (10 placebo-treated and 6 timolol-treated eyes). The mean PERG amplitude did not differ significantly between the placebo-treated and timolol-treated eyes. However, a significant correlation (r = -0.423) in the IOP differences between the placebo-treated and timolol-treated eyes and the corresponding PERG amplitude differences was noted in three of the four test conditions (i.e. 0.25, 0.5, and 1.0 degrees). These results suggest that reducing IOP may preserve ganglion cell function in some patients with ocular hypertension.
authors.affiliation: Department of Ophthalmology and Visual Science, Washington University School of Medicine, St Louis, MO 63110.
authors.forename: R
authors.initials: R
authors.lastname: Nesher
authors.forename: G L
authors.initials: GL
authors.lastname: Trick
authors.forename: M A
authors.initials: MA
authors.lastname: Kass
authors.forename: M O
authors.initials: MO
authors.lastname: Gordon
mesh_terms: D000368:Aged; D004596:Electroretinography / Q000187:drug effects*; D005260:Female; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D010364:Pattern Recognition, Visual; D011446:Prospective Studies; D013999:Timolol / Q000627:therapeutic use*
chemical_list: D013999:Timolol